How Reach Target works
|
|---|
What's in it for you?
|
4 reasons to care about reaching target:
|
|
DiscussionsWhat works? What doesn't? Join a thread or suggest a new topic. Currently being discussed: 1. What should happen to the centrifuges at the end of the study?2. Are registrars on new rotations keen to participate? What could make them more involved?3. Would you benefit from occasional conference calls with other sites?Awards: to be announced 26th May
|
|---|
|
Welcome and Study UpdateDr Susan Wagland, Trial ManagerAsk a questionKeynote Speaker: How Research improves NHS Clinical PracticeProf Keith Willett, Chief InvestigatorAsk a questionWhy PATH-2?Jacqueline Thompson, Research PhysiotherapistAsk a questionPlatelets: The Natural Wound Healers in the BloodDr Paul Harrison, University of Birmingham, co-investigatorAsk a questionAbout Substudy 1: Platelet Rich PlasmaAsk a questionView from a Site: Royal London HospitalJamila Kassam, Catherine Hilton, Shanaz Ahmad, Royal London Hospital
Ask a questionAbout Substudy 2: Tendon BiopsiesDr Philippa Hulley, University of Oxford, co-investigator[Video to follow]
Ask a question |
|
Survey and prize draw
Caption competitionLacking inspiration? get some and revisit - this will be updated daily Nominate a colleagueNominate a colleague for a special contribution award Contact usSend the study team a message (or email us on path-2.study@ndorms.ox.ac.uk)
|
